Imidafenacin on bladder and cognitive function in neurologic OAB patients

Clinical Autonomic Research

Volumn 23, Issue 4, 2013, Pages 189-195

  Sakakibara, Ryuji ^a   Tateno, Fuyuki ^a   Yano, Masashi ^a   Takahashi, Osamu ^a   Sugiyama, Megumi ^a   Ogata, Takeshi ^a   Haruta, Hiroyuki ^a   Kishi, Masahiko ^a   Tsuyusaki, Yohei ^a   Yamamoto, Tatsuya ^b   Uchiyama, Tomoyuki ^c   Yamanishi, Tomonori ^c   Yamaguchi, Chiharu ^c  

^a TOHO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cognitive function; Imidafenacin; Near infrared spectroscopy (NIRS); Overactive bladder; Prefrontal cortex

Indexed keywords

IMIDAFENACIN; OXYHEMOGLOBIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLADDER CAPACITY; BLADDER FUNCTION; COGNITION; DIABETIC NEUROPATHY; ENURESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEAR INFRARED SPECTROSCOPY; NEUROLOGIC EXAMINATION; OVERACTIVE BLADDER; POSTVOID RESIDUAL URINE VOLUME; PREFRONTAL CORTEX; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITY OF LIFE; QUESTIONNAIRE; SENSATION; URINARY FREQUENCY; URINARY URGENCY; URODYNAMICS;

EID: 84882273436     PISSN: 09599851     EISSN: 16191560     Source Type: Journal    
DOI: 10.1007/s10286-013-0200-3     Document Type: Article

References (24)

1. Abram P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology lower urinary tract function: report from the Standardisation Subcommittee of International Continence Society. Neurourol Urodyn 21:167-178
2. Robinson D, Cardozo L (2012) Overactive bladder: diagnosis and management. Maturitas 71:188-193
3. Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee (2005) An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 96:1314-1318
4. Fowler CJ, Griffiths D, de Groat WC (2008) The neural control of micturition. Nat Rev Neurosci 9:453-466
5. Sakakibara R, Uchiyama T, Yamanishi T, Kishi M (2008) Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population. Int J Urol 15:778-788
6. Chancellor M, Boone T (2012) Anticholinergics for overactive bladder therapy: central nervous system effects. CNS Neurosci Ther 18:167-174
7. Kobayashi F, Yageta Y, Yamazaki T, Wakabayashi E, Inoue M, Segawa M, Matsuzawa S (2007) Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task. Arzneimittelforschung 57:147-154
8. Yamada S, Seki M, Ogoda M, Fukata A, Nakamura M, Ito Y (2011) Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder. J Pharmacol Exp Ther 336:365-371
9. Sakakibara R, Shinotoh H, Uchiyama T, Sakuma M, Kashiwado M, Yoshiyama M, Hattori T (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci Basic Clin 92:76-85
10. Folstein M, Folstein S, McHugh PR (1975) Mini-mental state; a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
11. Rosen WG, Mohs RC, Davis KL (1984) A new rating scale for Alzheimer's disease. Am J Psychiatr 141:1356-1364
12. Dubois B, Slachevsky A, Litvan I, Pillon B, The FAB (2000) A frontal assessment battery at bedside. Neurology 55:1621-1626
13. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A (2006) Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 14:139-144
14. Laks J, Baptista EMR, Contino ALB, de Paula EO, Engelhardt E (2007) Mini-Mental State Examination norms in a community-dwelling sample of elderly with low schooling in Brazil. Cad Saúde Pública Rio de Janeiro 23:315-319
15. Salmon DP, Bondi MW (2009) Neuropsychological assessment of dementia. Annu Rev Psychol 60:257-282
16. Sakakibara R, Tsunoyama K, Takahashi O, Sugiyama M, Kishi M, Ogawa E, Uchiyama T, Yamamoto T, Yamanishi T, Awa Y, Yamaguchi C (2010) Real-time measurement of oxyhemoglobin concentration changes in the frontal micturition area: an fNIRS study. Neurourol Urodyn 29:757-764
17. Strangman G, Boas DA, Sutton JP (2002) Non-invasive neuroimaging using near-infrared light. Biol Psychiatry 52:679-693
18. Griffiths D, Tadic SD, Schaefer W, Resnick NM (2007) Cerebral control of the bladder in normal and urge-incontinent women. NeuroImage 37:1-7
19. Kitagawa Y, Kuribayashi M, Narimoto K, Kawaguchi S, Yaegashi H, Namiki M (2011) Immediate effect on overactive bladder symptoms following administration of imidafenacin. Urol Int 86:330-333
20. Homma Y, Yamaguchi O (2009) Imidafenacin Study Group. A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder. Int J Urol 16:499-506
21. Zaitsu M, Mikami K, Ishida N, Takeuchi T (2011) Comparative evaluation of the safety and efficacy of long-term use of imidafenacin and solifenacin in patients with overactive bladder: a prospective, open, randomized, parallel-group trial (the LIST Study). Adv Urol; 854697. Epub 2011 Oct 20
22. Yokoyama T, Koide T, Hara R, Fukumoto K, Miyaji Y, Nagai A (2012) Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: a prospective randomized controlled study. Urol Int. [Epub ahead of print]
23. Wada N, Watanabe M, Kita M, Matsumoto S, Osanai H, Yamaguchi S, Numata A, Fujisawa M, Saga Y, Hou K, Iuchi H, Niibori D, Kura T, Taniguchi A, Kunieda M, Nakata Y, Kakizaki H (2012) Effect of imidafenacin on nocturia and sleep disorder in patients with overactive bladder. Urol Int 89:215-221
24. Donnellan CA, Fook L, McDonald P, Playfer JR (1997) Oxybutynin and cognitive dysfunction. BMJ 315:1363-1364